Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Receivables (2017 - 2018)

Historic Receivables for Arcus Biosciences (RCUS) over the last 3 years, with Q2 2019 value amounting to $62000.0.

  • Arcus Biosciences' Receivables fell 8422.39% to $62000.0 in Q2 2019 from the same period last year, while for Jun 2019 it was $62000.0, marking a year-over-year decrease of 8422.39%. This contributed to the annual value of $183000.0 for FY2018, which is 26600.0% up from last year.
  • As of Q2 2019, Arcus Biosciences' Receivables stood at $62000.0, which was down 8422.39% from $183000.0 recorded in Q4 2018.
  • In the past 5 years, Arcus Biosciences' Receivables registered a high of $5.1 million during Q3 2018, and its lowest value of $50000.0 during Q4 2017.
  • Its 3-year average for Receivables is $982666.7, with a median of $145500.0 in 2018.
  • Per our database at Business Quant, Arcus Biosciences' Receivables soared by 26600.0% in 2018 and then plummeted by 8422.39% in 2019.
  • Quarter analysis of 3 years shows Arcus Biosciences' Receivables stood at $50000.0 in 2017, then surged by 266.0% to $183000.0 in 2018, then tumbled by 66.12% to $62000.0 in 2019.
  • Its Receivables was $62000.0 in Q2 2019, compared to $183000.0 in Q4 2018 and $5.1 million in Q3 2018.